Scientific Advisory Board Contact News Investors Medical Advisory Board Bioasis has assembled a team of exceptional oncology key opinion leaders. They will guide the clinical strategy and design of the xB3 TM -001 clinical program for the treatment of HER2+ breast cancer and brain metastases. Members of the Bioasis Medical Oncology Advisory Board are proven leaders in the field who will strengthen Bioasis’ oncology development. Their scientific insights will help Bioasis achieve its goal to revolutionize the treatment of brain metastases. May Orfali, M.D. Medical Advisor Javier Cortés, M.D., Ph.D. Medical Advisor John de Groot, M.D. Medical Advisor Hope S. Rugo, M.D. Medical Advisor Contact Policies © 2021 Bioasis Technologies, Inc.

Scientific Advisory Board Contact News Investors Leadership Team Bioasis has brought together a team of exceptional leaders from the biopharmaceutical industry. Their experience in collaborative research, drug development, alliances and commercialization provides the vision and expertise to enable Bioasis to revolutionize the treatment of neurological diseases. Deborah Rathjen, B.Sc. (Hons), Ph.D., MAICD, FTSE Executive Chair Dave Jenkins Chief Financial Officer Mei Mei Tian, Ph.D. Vice President, Head of External Research John Proffett Business Development Advisor Jeffrey Sprouse, Ph.D. Preclinical Program Manager Graeme Dick Director, Investor Relations Doris Westhoff, Ph.D. Project Manager Contact Policies © 2021 Bioasis Technologies, Inc.

Scientific Advisory Board Contact News Investors Board of Directors Our Board of Directors has extensive expertise in establishing and growing global businesses, product development, mergers and acquisitions, alliances and securing intellectual property in biotechnology and pharmaceutical businesses. Their judgment and perspectives guide Bioasis on our mission to deliver effective therapies across the blood-brain barrier into the brain. Deborah Rathjen, B.Sc. (Hons), Ph.D., MAICD, FTSE Executive Chair John E. Curran, CPA Director John Hemeon, MBA Director Mario Saltarelli, M.D., Ph.D. Director David M. Wurzer, CPA Lead Director Contact Policies © 2021 Bioasis Technologies, Inc.

Scientific Advisory Board Contact News Investors Scientific Advisory Board Members of the Bioasis Scientific Advisory Board are global leaders in driving discovery, development and commercialization. Their scientific insights allow Bioasis to explore new advances and to revolutionize the treatment of neurological disease. Professor John H. Krystal, M.D. Chairman Jeffrey L. Cummings, M.D. Member Mario Saltarelli, M.D., Ph.D. Member Jack Hoppin, Ph.D. Member Sue O’Connor, B.Sc. (Hons), Ph.D. Member John P. Wikswo, Jr., Ph.D. Member Contact Policies © 2021 Bioasis Technologies, Inc.